» Articles » PMID: 3041232

Discrimination Between Antibodies to HIV and to Related Retroviruses Using Site-directed Serology

Overview
Journal Nature
Specialty Science
Date 1987 Sep 17
PMID 3041232
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus (HIV) strains can be separated into two types: HIV and HIV-related West African viruses. Site-directed serology using synthetic peptides offers possibilities for the determination of type-specific antibodies. A 22-amino-acid peptide with the sequence Ala-Ile-Glu-Lys-Tyr-Leu-Glu-Asp-Gln-Ala-Gln-Leu-Asn-Ala-Trp-Cys-Ala-Phe-Arg-Gln - Val-Cys representing a conserved region of the transmembranous protein of simian T-cell lymphotropic virus-type III (STLV-III; related to West African HIV) was used as antigen in an enzyme-linked immunosorbent assay (ELISA). In parallel, tests were performed with a pair of previously described peptides, including the homologous region of the glycoprotein (gp) 41 of the HIV strain HTLV-IIIB. In tests with three groups of 20 sera it was shown that the different peptide ELISAs allowed a categorical distinction of antibodies to the two types of HIV. Tests using peptide antigens may provide excellent opportunities for large-scale testing for type-specific antibodies against HIV. The tests are simple, sensitive and specific and are readily standardized.

Citing Articles

Detection of Antibodies to Chlamydia trachomatis With Peptide-Based Species-Specific Enzyme Immunoassay.

Narvanen A, Puolakkainen M, Hao W, Kino K, Suni J Infect Dis Obstet Gynecol. 1997; 5(5):349-54.

PMID: 18476184 PMC: 2364578. DOI: 10.1155/S1064744997000616.


Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins.

Maria Marcelino J, Barroso H, Goncalves F, Silva S, Novo C, Gomes P J Clin Microbiol. 2006; 44(2):607-11.

PMID: 16455923 PMC: 1392652. DOI: 10.1128/JCM.44.2.607-611.2006.


Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.

Barin F, Meyer L, Lancar R, Deveau C, Gharib M, Laporte A J Clin Microbiol. 2005; 43(9):4441-7.

PMID: 16145089 PMC: 1234099. DOI: 10.1128/JCM.43.9.4441-4447.2005.


[HCV, HBV and HIV infections: risk for surgeon and staff. Results and consequences of routine screening in emergency patients].

Dresing K, Pouwels C, Bonsack S, Oellerich M, Schworer H, Uy A Chirurg. 2003; 74(11):1026-33.

PMID: 14605720 DOI: 10.1007/s00104-003-0741-4.


Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.

Merat R, Raoul H, Leste-Lasserre T, Sonigo P, Pancino G J Virol. 1999; 73(7):5698-706.

PMID: 10364320 PMC: 112629. DOI: 10.1128/JVI.73.7.5698-5706.1999.